Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5085-5092

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modifications of Nuclear Co-repressor RIP140: A Therapeutic Target for Metabolic Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-02 ,pp. : 386-392

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases

By  

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 714-745

Bentham Science Publishers

Access to resources Recommend Favorite

Current therapeutic leads for the treatment of autoimmune diseases: stem cell transplantation and inhibition of post-translational modifications of autoantigens

By Papanastasiou Anastasios D   Chatzantoni Kokona   Mouzaki Athanasia  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 10, 2008-10 ,pp. : 1255-1265

Informa Healthcare

Access to resources Recommend Favorite

Transglutaminase-Catalyzed Post-Translational Modifications of Proteins in the Nervous System and their Possible Involvement in Neurodegenerative Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 4, 2008-10 ,pp. : 370-375

Bentham Science Publishers

Access to resources Recommend Favorite